Flucytosine

This classification denotes a pyrimidine antagonist with the molecular formula C4H4FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D83282DT06, chemically known as 2(1h)-pyrimidinone, 4-amino-5-fluoro- (8ci)(9ci) but generally known as flucytosine, which bears US NIH Compound Identifier 3366. European Medicines Agency schedules Flucytosine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07676MIG. The term FLUCYTOSINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules flucytosine in its Anatomical Therapeutic Chemical (ATC) Classification. FLUCYTOSINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flucytosine under HS 29335995 and SITC 51576. As of Q4 2014, FLUCYTOSINE remains the US FDA Preferred Term for this commodity. Flucytosine bears US NLM identifiers UMLS ID C0016278 and NCI Concept Code C501. SMILES: FC1C([NH]C(=O)NC1)N.